ÂÜÀòÂÒÂ×

Mark Comer is currently a Research Assistant with the Dev Group at the Early Cancer Institute, Department of Oncology, at the University of Cambridge. Prior experience includes serving as a Junior Scientist at ProtonDx and a Postgraduate Researcher at Imperial College London, where Mark worked on significant projects related to metastatic breast cancer and drug-resistant triple-negative breast cancer. Earlier roles include a Summer Intern at the University of Cambridge, an Undergraduate Research Assistant at the National Heart & Lung Institute, and various internships, including an R&D position at Unilever and an Academic Mentor during the Imperial College London Global Summer School. Mark holds an MRes in Cancer Biology and a BSc in Biomedical Sciences from Imperial College London, as well as an IB Diploma from Bangkok Patana School.